Ethics and Dialogue

Societal scrutiny and dialogue

Life sciences and biotechnology have given rise to significant public attention and debate. Public debate remains of central importance: promoting dialogue among stakeholders and organising public debates will accompany and guide the development of life sciences and biotechnology and ensure effective, credible and responsible policies that are in harmony with societal values.

Dialogue in our democratic societies should be inclusive, comprehensive, well informed, structured and it should take place at the local and national levels, as well as internationally. Relevant public information is essential for meaningful dialogue. It is therefore of key importance to support information and dialogue to help the public and stakeholders better understand and appreciate these complex technologies.

Without broad public acceptance and support, the development and use of life sciences and biotechnology in Europe will be contentious and benefits will be delayed and competitiveness will likely suffer.

Ethical Values

Our society should offer the necessary safeguards to ensure that the development and application of life sciences and biotechnology take place respecting the fundamental values of human life and dignity.

Europe needs to achieve a common understanding among all stakeholders and policy makers and resolve any diverging views Europe is currently facing. If biotechnology is to work for Europe, political leaders must make some tough choices with mechanisms in place to handle the ethical dimension and to harness biotech’s potential so that it meets the needs and expectations of EU citizens.

To this end EuropaBio has developed a set of Core Ethical Values. All members of EuropaBio share these Core Ethical Values.
EuropaBio's core ethical values (October 1998) (| pdf - 12.1kb)

Ethics Working group

The Ethics group at EuropaBio is made up of representatives from among EuropaBio’s membership and it follows and contributes to the societal debate concerning the applications and development of biotechnology in all areas such as health, agriculture and industry.

chairman : Dr. Erik TAMBUYZER (Erik.Tambuyzer@genzyme.com)
secretary : Ms. Adeline FARRELLY (
a.farrelly@europabio.org)

 

Assessing BioEthical Practices


Click here to know more and to participate


 

 

 
Homepage  |   Contact  |   EuropaBio Team © 2000-2008   |  EuropaBio aisbl - VAT BE 477.520.310